4th Quarter - Report
AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety issues; Prescription drug abuse; H.R. 749, Lower Drug Costs Through Competition Act; CHIP reauthorization; Medicare extenders negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Pharmacy PHA
H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017); H.R. 2051, FAST Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.